- Why Research
- Our Impact
- Get Involved
- About BCRF
- Contact Us
- Cancer Divides. We Unite.
You are here
BCRF investigators develop checkpoint inhibitors to effectively treat breast cancer
The groundbreaking TAILORx Study is the largest trial of its kind with over 10,000 patients enrolled in 6 countries.
How randomized clinical trials can inform breast cancer prevention strategies
BCRF investigators try to understand the brain’s unique environment to prevent and treat brain metastasis.
An interview with BCRF researcher Dr. Anne McTiernan.
A BCRF researcher for two decades, Dr. Wigler shares his pioneering work in molecular biology.
BCRF investigator Kent Osborne discusses the successes, challenges and opportunities in treatment for HER2-positive breast cancer.
BCRF investigators discuss strategies to improve treatment in ER-positive breast cancer at the annual meeting of the American Association for Cancer Research.
After losing his mother to breast cancer at a young age, Michael Laursen is inspired by his company’s partnership with BCRF.
BCRF investigator Kornelia Polyak explains how tumors become a mixture of cells and how this relates to metastatic breast cancer.
Stay Up To Date
Don’t miss out. Let us update you when we post stories you care about.